Cargando…
Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible predictive factors influencing overall survival (OS), the development of relapse, infections, and the occurrence of gr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566995/ https://www.ncbi.nlm.nih.gov/pubmed/34760617 http://dx.doi.org/10.1016/j.lrr.2021.100274 |
_version_ | 1784594138833879040 |
---|---|
author | Belohlavkova, P Vrbacky, F Smolej, L Radocha, J Lanska, M Visek, B Kupsa, T Zavrelova, A Zak, P |
author_facet | Belohlavkova, P Vrbacky, F Smolej, L Radocha, J Lanska, M Visek, B Kupsa, T Zavrelova, A Zak, P |
author_sort | Belohlavkova, P |
collection | PubMed |
description | In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible predictive factors influencing overall survival (OS), the development of relapse, infections, and the occurrence of graft versus host disease (GvHD). In a univariate analysis, the pre-transplantation value of blasts in the marrow < 5% (p = 0.006), the revised International Prognostic Scoring System (IPSS-R) (p = 0.041), and karyotype (p = 0.009) were predictive of OS. Neither the elevation of serum ferritin (> 1000 ug/ml) nor increased C-reactive protein (CRP) (> 5 mg/l) was associated with shorter OS. In contrast, elevated serum lactate dehydrogenase (LDH) (> 213 U/l) was associated with shorter OS (p = 0.04). |
format | Online Article Text |
id | pubmed-8566995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-85669952021-11-09 Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome Belohlavkova, P Vrbacky, F Smolej, L Radocha, J Lanska, M Visek, B Kupsa, T Zavrelova, A Zak, P Leuk Res Rep Article In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible predictive factors influencing overall survival (OS), the development of relapse, infections, and the occurrence of graft versus host disease (GvHD). In a univariate analysis, the pre-transplantation value of blasts in the marrow < 5% (p = 0.006), the revised International Prognostic Scoring System (IPSS-R) (p = 0.041), and karyotype (p = 0.009) were predictive of OS. Neither the elevation of serum ferritin (> 1000 ug/ml) nor increased C-reactive protein (CRP) (> 5 mg/l) was associated with shorter OS. In contrast, elevated serum lactate dehydrogenase (LDH) (> 213 U/l) was associated with shorter OS (p = 0.04). Elsevier 2021-10-18 /pmc/articles/PMC8566995/ /pubmed/34760617 http://dx.doi.org/10.1016/j.lrr.2021.100274 Text en © 2021 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Belohlavkova, P Vrbacky, F Smolej, L Radocha, J Lanska, M Visek, B Kupsa, T Zavrelova, A Zak, P Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome |
title | Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome |
title_full | Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome |
title_fullStr | Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome |
title_full_unstemmed | Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome |
title_short | Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome |
title_sort | prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566995/ https://www.ncbi.nlm.nih.gov/pubmed/34760617 http://dx.doi.org/10.1016/j.lrr.2021.100274 |
work_keys_str_mv | AT belohlavkovap prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT vrbackyf prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT smolejl prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT radochaj prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT lanskam prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT visekb prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT kupsat prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT zavrelovaa prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome AT zakp prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome |